Ikarian Capital as of Dec. 31, 2019
Portfolio Holdings for Ikarian Capital
Ikarian Capital holds 91 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Intercept Pharmaceuticals In | 16.5 | $102M | 820k | 123.91 | |
| Intra Cellular Therapies (ITCI) | 6.6 | $41M | 1.2M | 34.31 | |
| SPDR S&P Biotech (XBI) | 5.4 | $33M | 350k | 95.11 | |
| Gilead Sciences (GILD) | 5.3 | $33M | 500k | 64.98 | |
| iShares NASDAQ Biotechnology Index (IBB) | 4.9 | $30M | 250k | 120.51 | |
| ArQule | 3.2 | $20M | 983k | 19.96 | |
| Mirati Therapeutics | 3.1 | $19M | 149k | 128.85 | |
| Apellis Pharmaceuticals (APLS) | 2.6 | $16M | 527k | 30.62 | |
| Allakos | 2.5 | $15M | 159k | 95.36 | |
| Sarepta Therapeutics (SRPT) | 2.1 | $13M | 103k | 129.04 | |
| Madrigal Pharmaceuticals (MDGL) | 2.1 | $13M | 145k | 91.11 | |
| Beigene (ONC) | 2.1 | $13M | 77k | 165.77 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.1 | $13M | 200k | 63.43 | |
| Gossamer Bio (GOSS) | 1.9 | $12M | 771k | 15.63 | |
| Biohaven Pharmaceutical Holding | 1.8 | $11M | 201k | 54.52 | |
| Gw Pharmaceuticals Plc ads | 1.7 | $11M | 100k | 104.56 | |
| Aurinia Pharmaceuticals (AUPH) | 1.6 | $9.7M | 481k | 20.26 | |
| Sage Therapeutics (SAGE) | 1.6 | $9.6M | 133k | 72.19 | |
| Ascendis Pharma A S (ASND) | 1.6 | $9.7M | 69k | 139.12 | |
| Immunomedics | 1.5 | $9.5M | 448k | 21.16 | |
| Immunovant (IMVT) | 1.3 | $8.0M | 504k | 15.87 | |
| Zogenix | 1.3 | $8.0M | 153k | 52.17 | |
| Global Blood Therapeutics In | 1.3 | $7.9M | 100k | 79.49 | |
| Crispr Therapeutics (CRSP) | 1.2 | $7.5M | 124k | 60.91 | |
| Incyte Corporation (INCY) | 1.1 | $7.0M | 80k | 87.32 | |
| Assembly Biosciences | 1.0 | $6.3M | 308k | 20.46 | |
| Deciphera Pharmaceuticals | 1.0 | $6.2M | 100k | 62.24 | |
| ACADIA Pharmaceuticals (ACAD) | 1.0 | $6.0M | 140k | 42.78 | |
| Aptose Biosciences | 0.9 | $5.7M | 1.0M | 5.67 | |
| Eidos Therapeutics | 0.9 | $5.7M | 100k | 57.39 | |
| Chiasma | 0.9 | $5.5M | 1.1M | 4.96 | |
| Anaptysbio Inc Common (ANAB) | 0.9 | $5.5M | 336k | 16.25 | |
| Clovis Oncology | 0.9 | $5.4M | 514k | 10.42 | |
| Kala Pharmaceuticals | 0.8 | $5.2M | 1.4M | 3.69 | |
| Ardelyx (ARDX) | 0.8 | $4.8M | 645k | 7.51 | |
| Amarin Corporation | 0.8 | $4.7M | 218k | 21.44 | |
| Adverum Biotechnologies | 0.7 | $4.5M | 391k | 11.52 | |
| Myokardia | 0.7 | $4.3M | 59k | 72.88 | |
| Otonomy | 0.7 | $4.1M | 1.1M | 3.83 | |
| Puma Biotechnology (PBYI) | 0.6 | $3.9M | 444k | 8.75 | |
| Karyopharm Therapeutics | 0.6 | $3.8M | 200k | 19.17 | |
| Kalvista Pharmaceuticals (KALV) | 0.6 | $3.8M | 212k | 17.81 | |
| Tg Therapeutics (TGTX) | 0.6 | $3.5M | 316k | 11.10 | |
| Wave Life Sciences (WVE) | 0.6 | $3.5M | 434k | 8.01 | |
| Viking Therapeutics (VKTX) | 0.6 | $3.4M | 426k | 8.02 | |
| Xenon Pharmaceuticals (XENE) | 0.5 | $3.2M | 244k | 13.11 | |
| Axsome Therapeutics (AXSM) | 0.5 | $2.9M | 28k | 103.37 | |
| Ocular Therapeutix (OCUL) | 0.5 | $2.8M | 708k | 3.95 | |
| Cerecor | 0.5 | $2.8M | 520k | 5.39 | |
| Cel Sci | 0.5 | $2.7M | 300k | 9.15 | |
| Agios Pharmaceuticals (AGIO) | 0.4 | $2.4M | 50k | 47.76 | |
| Bioxcel Therapeutics | 0.4 | $2.3M | 158k | 14.61 | |
| Ultragenyx Pharmaceutical (RARE) | 0.3 | $2.1M | 50k | 42.72 | |
| Aduro Biotech | 0.3 | $2.2M | 1.8M | 1.18 | |
| Chemocentryx | 0.3 | $1.8M | 46k | 39.55 | |
| Mallinckrodt Pub | 0.3 | $1.8M | 512k | 3.49 | |
| Macrogenics (MGNX) | 0.3 | $1.7M | 160k | 10.87 | |
| Coherus Biosciences (CHRS) | 0.2 | $1.5M | 84k | 18.00 | |
| Insmed (INSM) | 0.2 | $1.5M | 61k | 23.87 | |
| Ovid Therapeutics (OVID) | 0.2 | $1.5M | 350k | 4.15 | |
| Inflarx Nv (IFRX) | 0.2 | $1.4M | 359k | 3.96 | |
| Aimmune Therapeutics | 0.2 | $1.3M | 40k | 33.48 | |
| Solid Biosciences | 0.2 | $1.4M | 306k | 4.45 | |
| Mustang Bio | 0.2 | $1.3M | 323k | 4.08 | |
| Minerva Neurosciences | 0.2 | $1.2M | 175k | 7.11 | |
| Precision Biosciences Ord | 0.2 | $1.1M | 80k | 13.89 | |
| Axovant Gene The | 0.2 | $967k | 189k | 5.12 | |
| Applied Genetic Technol Corp C | 0.1 | $908k | 201k | 4.52 | |
| Neurocrine Biosciences (NBIX) | 0.1 | $774k | 7.2k | 107.50 | |
| Dbv Technologies S A | 0.1 | $798k | 75k | 10.71 | |
| Rigel Pharmaceuticals | 0.1 | $749k | 350k | 2.14 | |
| Progenics Pharmaceuticals | 0.1 | $666k | 131k | 5.09 | |
| Bellus Health | 0.1 | $625k | 64k | 9.81 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $552k | 78k | 7.05 | |
| Molecular Templates | 0.1 | $572k | 41k | 13.98 | |
| Prothena (PRTA) | 0.1 | $472k | 30k | 15.82 | |
| Chimerix (CMRX) | 0.1 | $351k | 173k | 2.03 | |
| Cara Therapeutics | 0.1 | $353k | 22k | 16.10 | |
| Dicerna Pharmaceuticals | 0.1 | $341k | 16k | 22.00 | |
| Obseva Sa | 0.1 | $315k | 83k | 3.81 | |
| Arvinas Ord (ARVN) | 0.0 | $254k | 6.2k | 40.97 | |
| Proteon Therapeutics | 0.0 | $138k | 336k | 0.41 | |
| Aeterna Zentaris | 0.0 | $107k | 117k | 0.91 | |
| Sierra Oncology | 0.0 | $131k | 386k | 0.34 | |
| Magenta Therapeutics | 0.0 | $131k | 8.7k | 15.10 | |
| X4 Pharmaceuticals | 0.0 | $107k | 10k | 10.70 | |
| Stealth Biotherapeutics Corp | 0.0 | $123k | 38k | 3.27 | |
| Novavax (NVAX) | 0.0 | $100k | 25k | 3.99 | |
| Pieris Pharmaceuticals | 0.0 | $80k | 22k | 3.64 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $38k | 111k | 0.34 | |
| Alpine Immune Sciences | 0.0 | $18k | 4.7k | 3.80 |
